EU finalizes deal with Pfizer-BioNTech for 1.8 billion doses
EU executive arm finalized a third vaccine contract with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses
EU executive arm finalized a third vaccine contract with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses